PALLAS: PALbociclib CoLlaborative Adjuvant Study: A randomized phase III trial of Palbociclib with standard adjuvant endocrine therapy versus standard adjuvant endocrine therapy alone for hormone receptor positive (HR+) / human epidermal growth factor receptor 2 (HER2)-negative early breast cancer

Sponsor
Alliance Pre-ECOG

Protocol Number
Alliance Foundation AFT-05 PrECOG0109 PALLAS

To Learn More Call
201-510-0910